Organization
Fundacion Clinic per a la Recerca Biomédica
9 clinical trials
Clinical trial
First in Human, Pilot, Open-label, Prospective, Multicentre, Non-randomised Clinical Trial to Evaluate the Safety and Efficacy of ARI0003 (CART CD19/ CD269 Cells) in Patients With Relapsed/Refractory B-cell Aggressive LymphomaStatus: Not yet recruiting, Estimated PCD: 2025-04-15
Clinical trial
A Phase II triAl of Cabozantinib for hepaTocellular carcInoma Patients intOlerant to Sorafenib Treatment or First Line Treatment Different to sorafeNib. (ACTION Trial)Status: Completed, Estimated PCD: 2023-02-22
Clinical trial
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected AdultsStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
The GOING Study: Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma Progressing Under Sorafenib or After Discontinuation of Atezolizumab Plus BevacizumabStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Clinical trial
EFFECTS OF ABATACEPT ON THE PROGRESSION TO RHEUMATOID ARTHRITIS IN PATIENTS WITH PALINDROMIC RHEUMATISM (PALABA)Status: Active (not recruiting), Estimated PCD: 2022-06-30
Clinical trial
Aspiration of Duodenopancreatic Juice After Secretin Stimulation (ADPJ-secr-) vs Endoscopic Aspiration (EUS-FNA) for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia (IPMN).Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected AdultsStatus: Active (not recruiting), Estimated PCD: 2024-11-15
Clinical trial
Open-label, Single-arm, Unicenter and Pilot Study of a Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-ResistanceStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients (LIVEDES)Status: Not yet recruiting, Estimated PCD: 2026-07-01